Advances in our understanding of how viruses hijack host cell machinery has opened new avenues of research in antiviral therapy development. How might this affect patients with infectious diseases?

Medscape One-on-One host Eli Adashi, MD, talks with Secretary of Health & Human Services Kathleen Sebelius about the new healthcare benefits offered to women under the ACA.

Dr. Paul Sax reviews data from the SINGLE trial presented at ICAAC 2012 on the benefits of dolutegravir/abacavir/lamivudine vs tenofovir/emtricitabine/efavirenz.

In his latest commentary, Bob Morrow talks about why the Affordable Care Act may provide an opening for physicians to organize for a greater voice in how they are paid.

Frank Veith talks about the Sunshine Act, what's wrong with it, and how it can be fixed.

Dr. Eric Topol is back with a topic that makes a lot of physicians very uncomfortable.

Many docs are confused about EHR certification and meaningful use. Dr. Karen Bell, chair of the Certification Commission for Healthcare Information Technology, sheds light on the key issues.

Dr. Paul Sax discusses a paper presented at the AIDS 2012 conference about the potential role of allogeneic stem cell transplantation in eradicating HIV over the long term.

What provokes the FDA to send a safety alert? And why do clinicians need to pay attention?

Dr. Paul Sax asks: Which populations will benefit most -- or least -- from the new FDA-approved HIV at-home test?